FIELD: medicine; pharmaceutics.
SUBSTANCE: nonsteroid antiinflammatory medical product in the form of a tablet covered with a film cover, including diclofenac or it pharmaceutically comprehensible salt as active substance and a cover including hydroxypropylmethicellulose, stearin acid and microcrystallic is presented.
EFFECT: protection of a tablet core, mainly, from moisture, oxygen and light and simplification of tablet swallowing.
11 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TABLETS OF CLOZAPINE WITH SUSTAINED RELEASE | 2016 |
|
RU2613192C1 |
| METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
| PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
| MODIFIED RELEASE 6-METHYL-2-ETHYL-HYDROXYPYRIDINE SUCCINATE DOSAGE FORM | 2008 |
|
RU2411035C2 |
| IMPROVED PHARMACEUTICAL PREPARATIONS CONTAINING IBUPROFEN AND CODEINE | 1995 |
|
RU2140782C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
| ORAL SOLID DOSAGE FORM AND METHOD OF TREATING | 2011 |
|
RU2480210C1 |
